Good afternoon :)
Switch to
Place Order

How to use scorecard? Learn more

Laurus Labs Ltd

LAURUSLABS
Health CarePharmaceuticals
MidcapWith a market cap of ₹16,447 cr, stock is ranked 246
Moderate RiskStock is 2.05x as volatile as Nifty
304.950.13% (-0.40)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

High

Strong financials and growth story over the years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹16,447 cr, stock is ranked 246
Moderate RiskStock is 2.05x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
17.904.900.65%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
32.713.960.99%

Forecast & RatingsDetailed Forecast 

55%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Laurus Labs Private Ltd is a research and development pharmaceutical company which manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Investor PresentationView older 

Jan 30, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+2.31+2.84+4.84+4.95+0.09+0.26+0.98+0.83
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnMar 13, 2023

Laurus Labs Limited has informed the Exchange about Schedule of meet | Download

Laurus Labs Limited has informed the Exchange about Schedule of meet | Download

Shareholders meeting 
Announced OnMar 10, 2023

Laurus Labs Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with scrutinizer report.. | Download

Laurus Labs Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with scrutinizer report.. | Download

Cash Dividend 
Ex. DateNov 3, 2022

Interim • Div/Share: ₹ 0.8

See all events